<DOC>
	<DOCNO>NCT00820820</DOCNO>
	<brief_summary>Atopic dermatitis ( AD ) chronic inflammatory disease skin . AD frequent , involve T lymphocytes cell . Measles vaccination , well measles vaccine , induces temporary immunosuppression ; furthermore , improvement AD observe measles infection . This trial aim demonstrating measles vaccine able create immunomodulation improve AD symptom . 30 adult patient sex moderate severe AD randomly assign measles vaccine ( ROUVAX ® ) , placebo ( vehicle ) follow-up 45 day . The primary outcome effect anti-measles vaccination T cell responses patient ; Other outcome include : clinical evolution AD , measure SCORAD , evolution blood level measles specific IgE antibody ; evolution biomarkers phenotypic characteristic T lymphocytes .</brief_summary>
	<brief_title>IDA ( Immunothérapie de la Dermatite Atopique ) Adult - Immunotherapy Atopic Dermatitis</brief_title>
	<detailed_description>Atopic dermatitis ( AD ) chronic inflammatory disease skin . AD frequent , involve T lymphocytes cell . Measles vaccination , well measles vaccine , induces temporary immunosuppression ; furthermore , improvement AD observe measles infection . This trial aim demonstrating measles vaccine able create immunomodulation improve AD symptom .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>adult patient sex , moderate severe Atopic Dermatitis ( SCORAD ( Score Atopic Dermatitis ) ≥ 15 ) . hypersensititvity contraindication Rouvax® component , Tubertest® component , egg protein , immunological deficiency , pregnancy , neomycin allergy , systemic immnosuppressive treatment previous 3 month , topic immunosuppressive treatment week preceeding inclusion ( glucocorticoid , immunosuppressive agent ) , fever acute disease ( inclusion must postpone case ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Atopic Dermatitis</keyword>
	<keyword>immunosuppression</keyword>
	<keyword>Measles vaccine</keyword>
	<keyword>T lymphocyte</keyword>
	<keyword>Atopic Dermatitis adult</keyword>
</DOC>